Screening for Atrial Fibrillation after Stroke
SCREENING AFTER STROKE - ATRIAL FIBRILLATION - the SIGNIFICANCE of TIMING and CHOICE of DEVICE
This study tests if checking for heart rhythm problems right after a stroke helps find more cases of atrial fibrillation compared to checking after leaving the hospital, and it also compares two different devices used for this screening.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 410 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Vestre Viken Hospital Trust Academic / other |
| Locations | 1 site (Sogneprest Munthe-kaas Vei 100, Gjettum) |
| Trial ID | NCT06675383 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of early screening for atrial fibrillation (AF) in patients who have experienced an ischemic stroke. It aims to determine whether screening conducted shortly after stroke onset leads to higher detection rates of AF compared to screening after hospital discharge. Additionally, the study will compare the efficacy of a 3-lead ECG device versus a 1-lead patch recorder in detecting AF. The findings could help refine guidelines for AF screening in stroke patients to improve secondary prevention strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who have experienced an ischemic stroke and do not have a known diagnosis of atrial fibrillation.
Not a fit: Patients who are diagnosed with atrial fibrillation at the time of hospital admission or have a life expectancy of less than one year may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved detection of atrial fibrillation in stroke patients, potentially reducing the risk of recurrent strokes through timely treatment.
How similar studies have performed: Previous studies have indicated that prolonged monitoring increases AF detection rates, suggesting that early screening may be beneficial, although this specific approach has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older * Ischemic stroke * Without known AF or those with previously diagnosed paroxysmal AF exhibiting sinus rhythm upon admission Exclusion Criteria: * AF at hosptial admission * Unable or unwilling to provide informed consent * A life expectancy of less than one year
Where this trial is running
Sogneprest Munthe-kaas Vei 100, Gjettum
- Vestre Viken Hospital trust, Baerum Hospital — Sogneprest Munthe-kaas Vei 100, Gjettum, Norway (Recruiting)
Study contacts
- Study coordinator: Håkon Ihle-Hansen, MD PhD
- Email: haaihl@vestreviken.no
- Phone: 0047-454-50633
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.